Joshua Joo

Array ( [id] => 7281342 [patent_doc_number] => 20040063719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Combination therapy using antihypertensive agents and endothelin antagonists' [patent_app_type] => new [patent_app_number] => 10/429197 [patent_app_country] => US [patent_app_date] => 2003-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13098 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063719.pdf [firstpage_image] =>[orig_patent_app_number] => 10429197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 864961 [patent_doc_number] => 07368480 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-06 [patent_title] => 'Methods and compositions with trans-clomiphene' [patent_app_type] => utility [patent_app_number] => 10/427768 [patent_app_country] => US [patent_app_date] => 2003-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5286 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/368/07368480.pdf [firstpage_image] =>[orig_patent_app_number] => 10427768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7075358 [patent_doc_number] => 20050148626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Novel thromodulin expression promoters' [patent_app_type] => utility [patent_app_number] => 10/511111 [patent_app_country] => US [patent_app_date] => 2003-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1977 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148626.pdf [firstpage_image] =>[orig_patent_app_number] => 10511111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7356266 [patent_doc_number] => 20040013708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Aqueous dispersible steryl ester compositions' [patent_app_type] => new [patent_app_number] => 10/411423 [patent_app_country] => US [patent_app_date] => 2003-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7100 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20040013708.pdf [firstpage_image] =>[orig_patent_app_number] => 10411423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7675699 [patent_doc_number] => 20040126419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Artificial tear formulation' [patent_app_type] => new [patent_app_number] => 10/404155 [patent_app_country] => US [patent_app_date] => 2003-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2933 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20040126419.pdf [firstpage_image] =>[orig_patent_app_number] => 10404155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730758 [patent_doc_number] => 20030186948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'O-linked N-acetylglucosamine pathway in the pathogenesis of neurodegeneration and diabetes' [patent_app_type] => new [patent_app_number] => 10/392508 [patent_app_country] => US [patent_app_date] => 2003-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 12889 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186948.pdf [firstpage_image] =>[orig_patent_app_number] => 10392508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7387063 [patent_doc_number] => 20040029869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Methods and compositions for treating or preventing sleep disturbances and associated illnesses using very low doses of cyclobenzaprine' [patent_app_type] => new [patent_app_number] => 10/392366 [patent_app_country] => US [patent_app_date] => 2003-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7123 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029869.pdf [firstpage_image] =>[orig_patent_app_number] => 10392366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7404017 [patent_doc_number] => 20040023948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Fast-dispersing dosage form containing 5-HT1 agonists' [patent_app_type] => new [patent_app_number] => 10/375560 [patent_app_country] => US [patent_app_date] => 2003-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6592 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023948.pdf [firstpage_image] =>[orig_patent_app_number] => 10375560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1068835 [patent_doc_number] => 06844361 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-18 [patent_title] => 'Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor' [patent_app_type] => utility [patent_app_number] => 10/358031 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3558 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/844/06844361.pdf [firstpage_image] =>[orig_patent_app_number] => 10358031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 917287 [patent_doc_number] => 07323463 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-29 [patent_title] => 'Combination of brimonidine and timolol for topical ophthalmic use' [patent_app_type] => utility [patent_app_number] => 10/357622 [patent_app_country] => US [patent_app_date] => 2003-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4026 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/323/07323463.pdf [firstpage_image] =>[orig_patent_app_number] => 10357622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7173440 [patent_doc_number] => 20050203189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Remedies for chronic kidney diseases' [patent_app_type] => utility [patent_app_number] => 10/502547 [patent_app_country] => US [patent_app_date] => 2003-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3746 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20050203189.pdf [firstpage_image] =>[orig_patent_app_number] => 10502547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5875388 [patent_doc_number] => 20060167032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Pharmaceutical composition and method for treating disorders of the central nervous system' [patent_app_type] => utility [patent_app_number] => 10/501678 [patent_app_country] => US [patent_app_date] => 2003-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6487 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20060167032.pdf [firstpage_image] =>[orig_patent_app_number] => 10501678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6830377 [patent_doc_number] => 20030181435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Treatment of SLE with dehydroepiandrosterone' [patent_app_type] => new [patent_app_number] => 10/340267 [patent_app_country] => US [patent_app_date] => 2003-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7928 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20030181435.pdf [firstpage_image] =>[orig_patent_app_number] => 10340267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740812 [patent_doc_number] => 20030158181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Method for treating cerebral ishaemia' [patent_app_type] => new [patent_app_number] => 10/336876 [patent_app_country] => US [patent_app_date] => 2003-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6423 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20030158181.pdf [firstpage_image] =>[orig_patent_app_number] => 10336876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6639432 [patent_doc_number] => 20030212034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Method of treatment of obesity and paralyzed muscle and ergogenic aids' [patent_app_type] => new [patent_app_number] => 10/297117 [patent_app_country] => US [patent_app_date] => 2002-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12844 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212034.pdf [firstpage_image] =>[orig_patent_app_number] => 10297117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7034344 [patent_doc_number] => 20050032854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Insulin resistance improving agents' [patent_app_type] => utility [patent_app_number] => 10/497378 [patent_app_country] => US [patent_app_date] => 2002-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8775 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032854.pdf [firstpage_image] =>[orig_patent_app_number] => 10497378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 923118 [patent_doc_number] => 07319090 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-15 [patent_title] => 'Methods of treating cerebral ischemia' [patent_app_type] => utility [patent_app_number] => 10/306672 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 9128 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/319/07319090.pdf [firstpage_image] =>[orig_patent_app_number] => 10306672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7470154 [patent_doc_number] => 20040102519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Use of arachidonic acid as a method of increasing skeletal muscle mass' [patent_app_type] => new [patent_app_number] => 10/306265 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1987 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102519.pdf [firstpage_image] =>[orig_patent_app_number] => 10306265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6739822 [patent_doc_number] => 20030157191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Methods and compositions for ameliorating the undesirable effects of chemotherapy' [patent_app_type] => new [patent_app_number] => 10/307245 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6065 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157191.pdf [firstpage_image] =>[orig_patent_app_number] => 10307245 [rel_patent_id] =>[rel_patent_doc_number] =>)